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Abstract 
Background: The toxicity of CdSe/ZnS quantum dots (QDs) in the environment and biological systems has become 
a major concern for the nanoparticle community. However, the potential toxicity of QDs on immune cells and its cor‑
responding immune functions remains poorly understood. In this study, we investigated the immunotoxicity of CdSe/
ZnS QDs using the in vitro in macrophages and lymphocytes and in vivo in BALB/c mice.
Results: Our results indicated that macrophages treated with 1.25 or 2.5 nM QDs exhibited decreased cell viability, 
increased levels of reactive oxygen species (ROS), elevated apoptotic events, altered phagocytic ability, and decreased 
release of TNF‑α and IL‑6 by upon subsequent stimulation with Lipopolysaccharide (LPS). In contrast, lymphocytes 
exposed to QDs exhibited enhanced cell viability, increased release of TNF‑α and IL‑6 following exposure with 
CpG‑ODN, and decreased transformation ability treatment in response to LPS. To study the in vivo effects in mice, 
we showed that QDs injection did not cause significant changes to body weight, hematology, organ histology, and 
phagocytic function of peritoneal macrophages in QDs‑treated mice. In addition, the QDs formulation accumulated 
in major immune organs for more than 42 days. Lymphocytes from QDs‑treated mice showed reduced cell viability, 
changed subtype proportions, increased TNF‑α and IL‑6 release, and reduced transformation ability in response to 
LPS.
Conclusions: Taken together, these results suggested that exposures to CdSe/ZnS QDs could suppress immune‑
defense against foreign stimuli, which in turn could result in increased susceptibility of hosts to diseases.
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Background
Quantum dots (QDs) are fluorescent semiconductor 
nanocrystals made of semiconductor materials such 
as CdTe or CdSe [1]. Many unique optical features 
of QDs make them useful for applications in biologi-
cal and medical fields. For example, they have excellent 
photoluminescence (PL) quantum yield, high photosta-
bility, broad absorption band with narrow emission spec-
tra, and size-tunable fluorescent peaks. Over the years, 
with increasingly large scale production and application, 
the likelihood of human exposing to QDs is highly pos-
sible. In particular, these nanocrystals have been found 
from environments as the degradation products. To 
date, the potential risks of QDs on the human health are 
largely unknown, as our knowledge of the in  vitro and 
in vivo toxicities remain elusive.
Recently published reports have provided limited infor-
mation about the toxicity of QDs to cells, and most toxi-
cological assessments were performed using in vitro and 
in  vivo models [2–4]. The in  vitro toxicities have been 
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assessed using a variety of cell models [5, 6]. However, 
the collected data is inconclusive owing to the intrinsic 
properties of QDs such as chemical components, size 
and surface modification [7, 8]. Moreover, little is known 
about the molecular mechanisms of the QDs-induced 
toxicity effects on immune cells [9]. In comparison to 
in  vitro investigations, there has been little informa-
tion about QDs-induced in  vivo toxicity [10, 11]. Previ-
ous studies have shown that QDs are accumulated in the 
spleen (which is one of important immune organs) when 
administrated through tail vein injection [3]. However, 
the consequent biological effects on immune functions 
were rarely addressed on the QDs exposure or accumula-
tion in the reticuloendothelial organs.
The immune system within an organism is a com-
plicated system of many biological components and 
processes. Both macrophages and lymphocytes (e.g. T 
lymphocytes, B lymphocytes and natural killer cells) are 
important immune cells which mediated the innate and 
adapted immunity of human body. Previously, we have 
reported that carboxyl-terminated CdSe/ZnS QDs inhib-
ited the cell proliferation of macrophages and the data 
showed that CdSe/ZnS QDs treatments indeed affect the 
cell viability of the macrophages [12]. But the molecular 
mechanisms responsible for QDs-mediated cytotoxic-
ity remain unknown. It is also not known whether QDs 
influence the immune function of macrophages or other 
immune cells toward immune stimulus such as bacterial 
endotoxin and viral nucleic acids. So far, only handful of 
reports about cytotoxicity of immune cells pertaining to 
QDs is available in the literature [9] and the potential risk 
of QDs in vivo in immune functions remains unexplored.
In this study, we used in  vitro and in  vivo screen-
ing strategies to evaluate the immunotoxicity of QDs 
exposures. The current study employed models of mac-
rophages and spleen-derived lymphocytes, which were 
previously used to evaluate the immune toxicity or 
response [4, 13, 14]. Basically, the cell uptake, viability, 
apoptosis and reactive oxygen species (ROS) generation 
were studied. And further studies were performed to test 
the effects of QDs on these cells in subsequent exposures 
to foreign substances including lipopolysaccharides (LPS) 
and CpG oligodeoxynucleotides (CpG-ODN) which are 
well-characterized immune stimuli recognizing differ-
ent types of Toll-like receptors [15, 16]. For in vivo assay, 
the biodistribution, hematology, organ histology, propor-
tion and functions of spleen derived lymphocyte, as well 
as phagocytic capacity of peritoneal macrophages from 
treated mice were determined at a relatively high concen-
tration (0.41 mg/kg of Cd). To our knowledge, this is first 
study to demonstrate QDs-induced immunologic func-




ZnS-coated CdSe QDs (CdSe/ZnS, Q21321MP) were 
purchased from Invitrogen Company. This core–shell 
material is coated with a polymer layer and it is termi-
nated with COOH surface groups. The photolumines-
cence emission spectra of CdSe/ZnS were measured by 
a Fluorescence spectrophotometer (Cary Eclipse, Agi-
lent, USA) with an excitation wavelength of 400  nm. 
UV–Visible-NIR absorption spectra were collected using 
a UV–Vis-NIR spectrophotometer (Cary 5000, Agilent, 
USA). The hydrodynamic size distribution of the CdSe/
ZnS was obtained by a dynamic light scattering (DLS) 
machine (Zetasizer Nano ZS, Malvern, UK). The mor-
phology of the CdSe/ZnS quantum dots was obtained 
with an FEI Tecnai G2 F20 S-TWIN transmission elec-
tron microscopy (TEM) operating at an accelerating volt-
age of 200 kV at room temperature.
Cell culture
Macrophage cell line RAW264.7 was obtained from 
American Type Culture Collection (ATCC) and cultured 
in Dulbecco’s modified Eagle’s medium (DMEM, Gibco, 
USA) supplemented with 10 % fetal bovine serum (FBS, 
Gibco, USA) and 100  U/mL penicillin/streptomycin 
(Gibco, USA). Mouse spleen lymphocytes were isolated 
from BALB/c mice and grown in RPMI 1640 medium 
with 10 % FBS. All cells were cultured at 37 °C in humidi-
fied 5 % CO2 atmosphere.
Laser scanning confocal imaging
The day before experiment, RAW264.7 macrophages 
(5.0  ×  105/dish) were seeded in 3.5  cm dishes. Mac-
rophages were left untreated or exposed to 1.25 and 
2.5 nM CdSe/ZnS QDs for 24 or 48 h. Then the cells were 
fixed, stained with DAPI, and imaged according to the 
procedure published previously [12].
Cell viability detected by WST assay
The cell viability of macrophages was evaluated by WST 
assay using Cell Counting Kit-8 kit (Dojindo, Japan). The 
day before assay, macrophages (1.0  ×  104 cells/well) or 
spleen lymphocytes (2.5 × 105 cells/well) were seeded in 
96-well plates. Cells were left untreated or treated with 
1.25 or 2.5 nM CdSe/ZnS QDs and incubated for 24 or 
48 h respectively. The CCK-8 assay solution (10 μL/well) 
was added and cells were incubated for 3 h. Absorbance 
was measured with a microplate reader (Multiskan FC, 
ThermoFisher, Finland) at a wavelength of 450  nm. The 
cell viability was calculated by normalizing the absorb-
ance of the sample well against that of the control well 
and expressed as a percentage, assigning the cell viability 
of non-treated cells as 100 %.
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Cell apoptosis detection by Western blot analysis
The day before assay, RAW264.7 macrophages (5.0 × 105 
cells/well) were seeded in 6-well plates. Cells were left 
untreated or exposed to 1.25, 2.5 nM CdSe/ZnS QDs for 
48 h. The medium was removed and cells were washed 
three times with PBS. Protein was extracted by the cold 
mammalian protein extraction reagent (Thermo, USA) 
according to the manufacturer’s instructions. A total of 
15  μg proteins were resolved by 12  % SDS-PAGE and 
transferred to 0.22  μm polyvinylidene difluoride mem-
branes (Millipore, USA). Membranes were soaked in 
blocking buffer (Skim Milk, China) for 1  h at room 
temperature and incubated with rabbit antibodies of 
GAPDH (1:1000, ABclonal, USA), Caspase-9 (1:1000, 
Proteintech, China), Caspase-3 (1:1000, Proteintech, 
China) at 4 °C overnight. Membranes were washed with 
TBST (10  mM Tris–HCL, 150  mM NaCl, and 0.05  % 
Tween 20) three times at 10  min interval. Membranes 
were incubated with goat anti-rabbit secondary antibod-
ies (1:1000, ABclonal, USA) for 1 h. Then the membranes 
were washed three times with TBST. Protein bands were 
visualized with clarity western ECL substrate (BioRad, 
USA) and the pictures were obtained by chemiscope 
western blot imaging system (Clinx science Instruments, 
China).
Detection of reactive oxygen species (ROS)
The production of cellular ROS was detected by the 
carboxy-dichlorofluorescein diacetate (carboxy-DCFH-
DA) assay. Briefly, 10  μM 2′-7′-Dichlorodihydrofluores-
cein diacetate (DCFH-DA) (Sigma-Aldrich, USA) was 
added to each well of 6-well plates for 4 h exposures. At 
the same time, cells were left untreated or treated with 
CdSe/ZnS QDs at 1.25, 2.5  nM respectively and cul-
tured for 4  h. Then the following assay was performed 
according to the manufacturer’s instructions. The signals 
of dichlorodihydrofluorescein (DCF) fluorescence were 
analyzed using a flow cytometry (FACS Calibur, BD, 
USA).
Measurement of cytokine production
RAW264.7 macrophages (1.0 × 104 cells/well) or spleen 
lymphocytes from normal mice (5 × 105 cells/well) were 
seeded in 96-well plates and cultured overnight. The 
cells were left untreated or treated with 1.25, 2.5 nM of 
CdSe/ZnS QDs respectively and incubated for 6  h. The 
cell medium was replaced and cells were stimulated 
with 8 ng/mL LPS or 10 μg/mL CpG-ODN (5′-TCCATG 
AGTTCCTGACGTT-3′) respectively for 24 h (37 °C, 5 % 
CO2). The levels of TNF-α and IL-6 in culture superna-
tants were measured using enzyme-linked immunosorb-
ent assay (ELISA) (eBioscience, USA), according to the 
manufacturer’s instructions.
Neutral red uptake assay
The phagocytic capacity of macrophages was detected 
by neutral red uptake assay (Beyotime, China). The cells 
(1.0  ×  104 per well) were seeded in 96-well plate and 
incubated overnight. The cells were treated with 1.25 
or 2.5  nM CdSe/ZnS QDs for 2, 4, 6 and 24  h respec-
tively. After that, 20 μL neutral red solutions were added 
into each well and the cells were incubated for 2 h. The 
medium was removed and the cells were washed with 
PBS once. Then 200  μL of lysis buffer was added into 
each well and the wells were incubated at room tempera-
ture for 10 min with constant slight shaking. The absorp-
tion of the wells was read at a wavelength of 540 nm by a 
microplate reader (Multiskan FC, ThermoFisher, Finland) 
and the uptake efficiency was calculated by normaliz-
ing the absorbance of the sample well against that of the 
control well and expressed as a percentage, assigning the 
phagocytic ability of non-treated cells as 100 %.
Transformation assay
Spleen lymphocytes from normal mice were seeded in 
96-well plates (2.5  ×  105/well) and exposed to 1.25 or 
2.5  nM CdSe/ZnS QDs and incubated for 6  h. Lympho-
cytes from untreated mice were set as control. The cells 
were subsequently stimulated with 1.25 μg/mL LPS or 8 μg/
mL ConA (Concanavalin A) for 48 and 72 h. Then 10 μL 
CCK-8 solutions was added and incubated for 4 h. Absorb-
ance was measured with a microplate reader (Multiskan 
FC, ThermoFisher, Finland) at a wavelength of 450  nm. 
The lymphocyte transformation percentage was calculated 
according to the following formulas: (ODafter stimulation− 
OD before stimulation)/QD before stimulation × 100.
Animals, blood test, biodistribution analysis and H and E 
staining
BALB/c male mice of 6-week-old were obtained from 
Laboratory Animal Center of Guangdong Province and 
housed in individual ventilation cages in a 12/12 h light/
dark cycle. The animal experiments were carried out in 
accordance with recommendations cited in the Guide for 
the Care and Use of Laboratory Animals of Laboratory 
Animals Center of Shenzhen University. And the pro-
ject and protocols were approved by the Experimental 
Animal Ethics Committee of Shenzhen University (Per-
mit no.201412012). The mice were injected with 200 μL 
of PBS or buffered QDs dispersion (2  nmol/kg) by tail 
vein. After injection, body weight of mice was measured 
on Day 1, 3, 7, 14, 30, 42 respectively. On Day 1 and Day 
42 after the injection, mice of each group were sacrificed. 
Blood samples were harvested and blood routine exami-
nation was performed using the whole blood by a routine 
blood test instrument (RJ-0C107223, Mindray, China). 
The fresh major organs were dissected, weighed and 
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organ index was calculated (organ weight/body weight). 
The tissues were selected for frozen section examina-
tion and H and E (haematoxylin and eosin) staining. Fro-
zen section was prepared using a freezing microtome 
(CM3050S, Leica, Germany) and imaged by a fluorescent 
microscope (BX51, Olympus, Japan). The amounts of 
heavy metal elements in the blood and tissue were deter-
mined by inductively coupled plasma mass spectrometry 
(ICP-MS) (7500C1, Agilent, USA) analysis according to 
the protocol previously published [10].
Analysis of spleen‑derived lymphocytes from treated mice
The mice were injected with 200  μL of PBS or buffered 
QDs dispersion by tail vein. 42 days later, the mice were 
sacrificed. The spleen was dissected and total lympho-
cytes were harvested for cell viability assay, subset anal-
ysis, cytokine release analysis and transformation assay. 
For analysis of subset, 1 × 106 spleen lymphocytes were 
collected and washed with cell staining buffer (Biolegend, 
USA) once, resuspended with 100 μL staining buffer, and 
stained with anti-CD3ɛ FITC (1 μg), anti-CD19 PE (0.25 μg) 
and anti-CD49b PerCP (0.25 μg) for 20 min. The supernant 
was removed after centrifugation of 1000 rpm for 5 min. 
Then the cells were washed with staining buffer once, 
resuspended in 500 μL PBS buffer and immediately ana-
lyzed by flow cytometry (FACS Calibur, BD, USA). Cell 
viability assay, cytokine release analysis and transforma-
tion assay were performed according to the methods 
described above.
Statistical analysis
All experimental data were presented as the mean  ±   
standard deviation (SD). T test was employed to assess 
the mean of the two groups and the mean difference 
among the groups compared to control by analysis of 
variance (ANOVA). P < 0.05 was considered to indicate a 
statistically significant difference.
Results
Characterization of the CdSe/ZnS QDs
We first showed that the maximum emission for the 
CdSe/ZnS is 655  nm from the florescence spectra 
(Fig. 1A). Figure 1B showed the TEM image of CdSe/ZnS 
QDs. The average hydrodynamic diameter of CdSe/ZnS 
was around 8  nm (Fig.  1C). When the CdSe/ZnS QDs 
were kept at 4  °C, no aggregation or precipitation was 
observed during the period of storage, suggesting that the 
CdSe/ZnS QDs nanocrystals are highly monodispersed.
Uptake of the CdSe/ZnS QDs by immune cells
As shown in Fig.  1D, the confocal images of CdSe/ZnS 
QDs treated mouse macrophages indicated that the flu-
orescent signal was detectable even after 24 or 48  h of 
treatment. These observations suggest that the CdSe/ZnS 
QDs can be taken up by macrophages and stayed in cells 
continuously for over 48 h without being digested or dis-
charged. As the adherent ability of lymphocytes is poor 
and cells are easy to detach from the cultured dishes, 
we determined the uptake of CdSe/ZnS QDs by lym-
phocytes using flowcytometry assay instead of confocal 
imaging. As shown in Additional file  1: Figure S1, lym-
phocytes treated with CdSe/ZnS QDs had negative fluo-
rescent signal, suggesting that the QDs can’t go into the 
lymphocytes.
Effect of in vitro exposure to QDs on macrophages
As shown in Fig.  2A, the cell viability of macrophages 
treated with CdSe/ZnS QDs for 24 or 48  h was signifi-
cantly lower than that of the untreated cells. In addition, 
the cell viability of macrophages treated with three other 
types of QDs was also detected by MTT assay and the 
results showed the same trend (Additional file 1: Figure 
S4). To probe the mechanism of cytotoxicity, the produc-
tion of cellular ROS and apoptotic events were examined. 
Figure 2B, C showed that treating macrophages with 1.25 
and 2.5 nM QDs for 4 h resulted in significant increase in 
intracellular ROS level. Figure 2E, F showed the protein 
expression levels of Caspase 9 and Caspase 3 which are 
involved in the activation cascade of Caspases respon-
sible for apoptosis execution. Our data showed that 
the expression of cleaved Caspase 3 and Caspase 9 sig-
nificantly increased in the RAW264.7 cells treated with 
CdSe/ZnS QDs, suggesting increased apoptotic events 
occurred in the cells. Phagocytosis is another important 
function of macrophages. As shown in Fig. 2D, 1.25 nM 
QDs treatment reduced the phagocytic activity at 24  h 
post-treatment. When treated with 2.5  nM QDs, a sig-
nificant decrease in phagocytic activity was observed at 
2 or 24 h post-treatment, but surprisingly, an increase in 
phagocytic ability were observed at 4 and 6 h after treat-
ment. These results suggested that QDs treatment caused 
immune dysfunction in macrophages.
In addition, we also exposed macrophages first with 
CdSe/ZnS QDs for 6 h and then stimulated with LPS and 
CpG-ODN, which are well known immune stimuli recog-
nizing different types of Toll-like receptors. As shown in 
Fig.  2G, macrophages treated with 1.25 or 2.5  nM QDs 
showed no change in the release of IL-6 and TNF-α after 
exposure to CpG-ODN. However, significantly lower 
amounts of IL-6 and TNF-α secretion were observed 
when stimulated with LPS (Fig. 2H).
Effect of in vitro exposure to QDs on spleen‑derived 
lymphocytes
In lymphocytes, CdSe/ZnS QDs exposure alone led to 
enhanced cell viability (Fig. 3A). We further investigated 
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the effect of CdSe/ZnS QDs on transformation ability 
of lymphocytes after subsequent exposure to ConA and 
LPS. As we know, when lymphocytes are activated, the 
cells will transform into lymphocytoblasts with increased 
volume and metabolic activity. As shown in Fig.  3B, 
after subsequent exposure to ConA for 48 or 72 h, lym-
phocytes treated with 1.25 and 2.5  nM CdSe/ZnS QDs 
showed no significant change in transformation abilities 
as compared to untreated cells. However, when the lym-
phocytes were subsequently stimulated by LPS, CdSe/
ZnS QDs treatment at 1.25  nM caused no observed 
change in transformation ability at 48 h, but resulted in 
obvious decrease at 72 h (Fig. 3C). In addition, when the 
dosage of QDs reached 2.5  nM, the activation abilities 
of lymphocytes towards LPS were obviously inhibited 
at both 48 and 72-hour time points. Figure  3D, CdSe/
ZnS QDs exposure alone caused no significant change 
in the release of IL-6 and TNF-α. When lymphocytes 
were subsequently stimulated by CpG-ODN, the levels of 
cytokines released by lymphocytes remained unchanged 
at the dose of 1.25  nM, but increased at the dose of 
2.5 nM (Fig. 3E).
In vivo distribution of QDs in the blood and major immune 
organs
To evaluate the immunotoxicity of QDs in  vivo, CdSe/
ZnS QDs were administered into the mice intravenously. 
In order to assess the dose of CdSe/ZnS QDs formulation, 
Fig. 1 Characterization of CdSe/ZnS QDs and uptake of CdSe/ZnS QDs by macrophages. A The photoluminescence emission and absorption spec‑
tra. B TEM image of CdSe/ZnS QDs. C The hydrodynamic size distribution of the CdSe/ZnS QDs. D Fluorescent images of RAW264.7 macrophages 
treated with CdSe/ZnS QDs for 24 and 48 h. Left, middle and right panels are DAPI signal, QDs signal and merged images, respectively. The cell 
nucleus was stained with DAPI (pseudo-colored in blue) and the signals from the QDs were in red
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we first performed ICP-MS analysis to calculate the 
concentrations of Cd, Se and Zn. Our results indicated 
that the CdSe/ZnS QDs formulation we injected cor-
responded to 0.41 mg/kg of Cd, 0.012 mg/kg of Se, and 
0.0364  mg/kg of Zn. On Day 1 and 42 after injection, 
mice were sacrificed; their major organs were dissected 
for fluorescence imaging. Our results showed that strong 
fluorescence signals were observed in the spleen and liver 
even at 42 days post-injection (Fig. 4A). The fluorescence 
signals were also detectable in thymus. However, little 
fluorescence signal was detected in the lung, heart, kid-
ney or brain (data not shown). These results manifested 
that the majority of CdSe/ZnS QDs were taken up by the 
immune organs and remain intact with sustainable fluo-
rescence emitting ability.
To further quantify the accumulation of cadmium 
derived from CdSe/ZnS QDs, the concentrations of Cd 
and Se in the blood and tissues were measured by ICP-MS 
analysis. Figure 4B showed the Cd concentration in blood 
circulation at 2 h, 4 h, 6 h and 24 h after injection. After 
injection, the initial concentration of Cd is approximately 
5.46  μg/mL. At 2 and 4  h, the Cd concentration was 
0.15 ±  0.022 and 0.11 ±  0.018  μg/mL, respectively, but 
at 6 and 24 h, the Cd concentration in blood decreased 
to 0.09 ±  0.009 and 0.028 ±  0.003  μg/mL, respectively. 
The blood clearance profile revealed that the CdSe/ZnS 
QDs can be cleared by the blood quickly. Figure  5C–D 
shows the Cd concentration in major organs on Day 1 
and Day 42 after injection. The Cd element was found 
to accumulate in all the tested organs, including heart, 
liver, spleen, lung, kidney, brain and thymus on Day 1 and 
Day42. The Cd concentrations in spleen and thymus were 
13.12 ±  3.885 and 0.29 ±  0.065  μg/g on Day 1, respec-
tively. On Day 42, the Cd component still remarkably 
accumulated in spleen and thymus, where the Cd con-
centrations were 24.05  ±  7.651 and 0.16  ±  0.071  μg/g, 
respectively. In addition, we also determined the Se con-
centration in blood and major organs (Additional file 1: 
Figure S2), and our data showed that Se element from 
CdSe/ZnS QDs had predominantly accumulated in the 
spleen and liver.
Effects of in vivo exposure to QDs on WBC quantity, 
immune organ index and histomorphology
To further investigate the immunotoxicity effects and 
biocompatibility of CdSe/ZnS QDs formulation in  vivo, 
the body weight and immune organ index of mice were 
monitored, and no significant difference was observed 
between QDs-treated and untreated animals (Fig. 5A, B). 
Blood routine examination was performed to determine 
Fig. 2 Effect of in vitro exposure to QDs on macrophages. A Cell viabilities of RAW264.7 macrophages treated with QDs (n = 5). B Flow cytometry 
analysis of DCF fluorescence reflecting intracellular ROS level in RAW264.7 macrophages treated with QDs for 4 h. C Statistical analysis of ROS level 
in RAW264.7 macrophages (n = 3). D Neutral red uptake ability of RAW264.7 macrophages after exposure to QDs for 2, 4, 6 and 24 h (n = 6). E Rep‑
resentative pictures of Western blot analysis. F Densitometric analysis of protein expression levels of cleaved Caspase 3 and Caspase 9. (*P < 0.05, 
**P < 0.01, ***P < 0.001 vs. control). G and H The levels of TNF‑α or IL‑6 released by RAW264.7 macrophages after re‑stimulation with CpG or LPS 
(n = 6). All values are mean ± SD, *P < 0.05 vs. control, **P < 0.01 vs. control
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the quantity of white blood cells (WBC) in blood. The 
quantity of WBC in blood reflects the overall immu-
nity of the body and assisting in proofing the presence 
of inflammation. Figure 5C showed that no difference in 
WBC quantity between these two groups, suggesting no 
inflammation existed in the mice with CdSe/ZnS QDs 
exposure. Besides WBC, other major blood biomark-
ers including red blood cell count (RBC), Hemoglobin 
(Hb), hematocrit (Hct), Platelet (Plt), mean corpuscular 
volume (MCV) and mean platelet volume (MPV) were 
analyzed. Our results showed that all measured factors 
were within normal ranges (data not shown). In addition, 
H and E staining was performed to observe the histologi-
cal changes of spleens from mice at Day 1 and Day 42. 
Figure 5D showed no pathological injury in the structure 
of the spleens from treated mice.
In vivo exposure to QDs caused the dysfunctions 
of immune cells in vivo in BALB/c mice
To evaluate the in  vivo effect of QDs exposure on the 
immune cells, we first analyzed the subsets of lympho-
cytes, T lymphocytes (CD3ɛ+), B lymphocytes (CD19+) 
and NK lymphocytes (CD49b+) from treated mice using 
flowcytometry. As shown in Fig. 6A, B, exposure to CdSe/
ZnS QDs resulted in decreased percentage of CD3ɛ+-T 
lymphocytes, increased percentage of CD19+-B lym-
phocytes, but caused no effects on the proportion of 
CD49b+-NK cells in total lymphocytes from mice. In addi-
tion, Fig. 6C showed that CdSe/ZnS QDs exposure led to 
decreased cell viability of total lymphocytes. To further 
evaluate the in  vivo immune ability of QDs-treated mice, 
the chicken erythrocytes phagocytosis assay was performed 
(Additional file  1: Figure S3A). Additional file  1: Figure 
S3B, S3C showed no significant differences in phagocytic 
percentage between QDs-treated or PBS-treated mice. 
In addition, the immune functions of lymphocytes from 
treated mice were evaluated. Figure 6D, lymphocytes from 
QDs-treated mice showed increased release of IL-6 and 
TNF-α as compared to those from PBS-treated mice. In 
addition, the transformation ability of lymphocytes was 
determined to analyze immune function of the response 
to foreign stimulus. As shown in Fig.  6E, CdSe/ZnS QDs 
treatment resulted in a decrease of transformation abil-
ity when lymphocytes were exposed to LPS. These results 
suggested that the immune functions of lymphocytes from 
spleen are indeed affected by the CdSe/ZnS QDs exposure.
Discussions
Previously, we have reported the cytotoxicity effects of 
commercial carboxyl-terminated CdSe/ZnS QDs on 
Fig. 3 Effect of in vitro exposure to QDs on spleen‑derived lymphocytes. A Cell viabilities of lymphocytes treated with QDs for 24 or 48 h (n = 5). 
B and C Activation abilities of lymphocytes treated with QDs in response to ConA or LPS (n = 6). D, E The levels of TNF‑α or IL‑6 released by QDs‑
pretreated lymphocytes after re‑stimulation with PBS or CpG (n = 6). All the values are the mean ± SD, *P < 0.05 vs. control, **P < 0.01 vs. control
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RAW264.7 murine macrophage cells (Lin et  al. 2014). 
Here we extend the study using in  vitro immune cell 
model and in  vivo BALB/c mice. In the present work, 
we investigate the potential molecular mechanism of 
CdSe/ZnS QDs-induced cytotoxicity and the corre-
sponding effects of CdSe/ZnS QDs on the innate and 
adapted immunity of immune cells towards exogenous 
substances.
Cadmium containing QDs such as CdTe and CdSe 
have been shown to induce toxicity in  vitro cell model 
[17]. Here, our data showed that CdSe/ZnS QDs can be 
captured by macrophages but not by lymphocytes. It is 
not surprising because macrophages are specific immune 
cells with phagocytic ability. In addition, our data showed 
that CdSe/ZnS QDs exposure led to a decrease in cell 
viability of macrophages, which is largely consistent 
with previous studies using different cell lines [8, 18] 
and immune cells [4]. Conversely, CdSe/ZnS QDs treat-
ment caused enhanced cell viability of lymphocytes. 
Such phenomena might be resulted from the difference 
between these two cell types. Previously, Shiohara et al. 
tested the QDs sensitivity to different cell lines and dem-
onstrated that cytotoxicity was dependent on the cell 
type exposed [19]. RAW264.7 macrophage cell line is 
immortalized with rapid proliferation and phagocytic 
ability, but total lymphocytes are primary cells derived 
from mouse spleen with limited multiplication  capac-
ity but strong transformation ability. In response to an 
immune stimulus, part of small lymphocytes transform 
into immature mother cells and go under mitosis, which 
lead to increase cell density and viability. These data sug-
gested that CdSe/ZnS QDs exposure alone will impair 
the macrophage cell viability, but lead to lymphocyte 
transformation.
Previous studies suggested that ROS generation plays a 
key role in the toxicological profile of nanomaterials [20, 
21]. Our data showed an increase of intracellular ROS 
level in macrophages with 4-h exposure of CdSe/ZnS 
Fig. 4 In vivo distribution of QDs in blood and major immune organs. A Fluorescence images of liver, spleen and thymus of the mice emitted by 
QDs on Day 1 and Day 42 after injection. B ICP‑MS analysis of Cd concentrations in blood at 2, 4, 6 and 24 h after injection. C and D ICP‑MS analysis 
of Cd concentrations in major organs from QDs‑treated mice on Day 1 and Day 42 after injection
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QDs, which align to some extent with the previous study 
retaining cadmium-based QDs in other cell types [4]. In 
fact, for each type of nanoparticles with different compo-
nent, size, and surface modification, the corresponding 
mechanisms of nanoparticles-induced ROS generation 
will be different in many ways [22]. Apoptosis has been 
described as a major mechanism of cell death induced 
by nanoparticle-induced oxidative stress [23]. Here our 
data showed that an increase in apoptosis event in cells 
with QDs exposure, which is consistent with previous 
study [4]. Taken together, the results on cell uptake, via-
bility, ROS generation and apoptosis indicate that CdSe/
ZnS QDs can enter immune cells with exerting obvious 
cytotoxicity. However, cell function is another important 
parameter that might change when the QDs are present 
within the cells. To date, little toxicological data is avail-
able for the examination of the toxicity effects of QDs 
on macrophages and lymphocytes and the correspond-
ing responses of immune cells towards physiological 
stimulus.
In this study, we first assessed whether macrophages 
and lymphocytes, which had been first exposed to CdSe/
ZnS QDs, were still able to behave normally in response 
to LPS and CpG-ODN. LPS, also known as endotoxin, is 
a large molecule consisting of a lipid and a polysaccharide 
found in Gram-negative bacteria, and they elicit strong 
immune responses in animals [15]. CpG-ODN is a short 
unmethylated single-stranded synthetic DNA molecule 
that has immunostimulatory properties [16]. Our in vitro 
data showed the release of cytokines of macrophages in 
response to CpG-ODN was not significantly affected by 
CdSe/ZnS QDs, but remarkably suppressed in response 
to LPS. This inconsistent result is not surprising because 
LPS and CpG-ODN are different immune stimuli and 
mediate the immune response by different pathway. 
Both LPS and CpG-ODN are highly conserved struc-
tural motifs known as pathogen-associated microbial 
patterns (PAMPs), which can be recognized by different 
Toll-Like Receptors (TLRs) expressed on macrophages. 
LPS detects TLR4, but unmethylated CpG DNA recog-
nizes TLR9 [24]. Here, our data indicated that CdSe/ZnS 
QDs pretreatment will influence the LPS-TLR4 pathway 
activation, but has no effect on the biological activities of 
TLR9 pathway.
The present study goes further to investigate the influ-
ence of CdSe/ZnS QDs on macrophages and lymphocytes 
functionality. The phagocytic activity of macrophages and 
the transformation ability of lymphocytes with CdSe/ZnS 
QDs pre-treatment were determined. Our data showed the 
phagocytic activity of macrophages was decreased after 
Fig. 5 Effects of in vivo exposure to QDs on body weight, WBC quantity, immune organ index and histomorphology. A The weights of mice were 
monitored after injection of CdSe/ZnS QDs/buffer solution through tail vein during 42 days period. B Major immune organ index of treated mice. C 
Quantity of white blood cells in blood. D HE staining of spleen from QDs‑treated or untreated mice
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2 h CdSe/ZnS QDs treatment, but subsequently enhanced 
after 4 and 6 h treatment. The influence of CdSe/ZnS QDs 
on macrophages was discovered to be non-time dependent. 
Such phenomena might be resulted from the competitive 
uptake process between the neutral red and QDs because 
CdSe/ZnS QDs was mainly captured by macrophages 
within 2  h [12], which resulted in decreased uptake of 
the neutral red. However, 2 h later, the QDs-treated mac-
rophages were activated, and the uptake ability of them 
was elevated. In addition, we found a significant inhibited 
uptake ability of macrophages after 24 h treatment, which 
is possibly owing to the decreased cell viability as described 
above. As we known, healthy cells with intact lysosomes 
will take up more neutral red dye than those dead cells or 
cells undergoing apoptosis [25]. In addition, our results 
showed that the transformation ability of CdSe/ZnS QDs 
pretreated-lymphocytes towards LPS was inhibited. These 
results are not contradictory when compared to those in 
response to ConA because LPS and ConA are different 
immune stimuli, which activate different types of lympho-
cytes. ConA mainly stimulate T cell proliferation, while 
LPS mainly stimulate B cell proliferation.
To substantiate the in vitro finding of Cds-induced dys-
function on immune cells, we performed in vivo exposure 
of CdSe/ZnS QDs in BALB/c mice. QDs are within the 
size range of viruses and large protein, and consequently 
they may arouse an inflammatory response. The ICP-MS 
analysis of blood sample revealed that the   CdSe/ZnS 
QDs can be cleared from the blood quickly. Once the 
QDs are cleared from the blood stream, they will migrate 
to tissues or organs. The spleen and thymus, consisting of 
B and T lymphocytes and accessory cells including mac-
rophages, are the major immune organs. We found that 
the fluorescence of  CdSe/ZnS QDs injected into BALB/c 
can be detected in spleen and thymus for up to 42 days 
post injection. Consistent with our finding, several stud-
ies have reported the similar accumulation pattern of 
cadmium-based Ads in animal models [11]. Choi et  al. 
showed that QDs (<5.5 nm) were able to be cleared from 
the body through the kidney and no accumulation of 
QDs was observed in the major organs of Sprague–Daw-
ley (SD) male rats [26]. In our case, the  CdSe/ZnS QDs 
are remained the body because the hydrodynamic diam-
eter of the  CdSe/ZnS QDs are greater than 6.5 nm. Thus, 
Fig. 6 In vivo exposure to QDs caused dysfunctions of immune cells in BALB/c mice. A Representative FACS pictures describing the subsets of 
spleen lymphocytes from untreated or treated mice. a–c control; d–f QDs. B Statistical analysis of T lymphocytes (CD3ɛ+), B lymphocytes (CD19+) 
and NK lymphocytes (CD49b+) (n = 5). C Cell viability of spleen lymphocytes from QDs‑treated mice on Day 42 (n = 4). D Cytokines release of 
spleen lymphocytes from QDs‑treated or untreated mice (n = 4). E Activation ability of lymphocytes from QDs‑treated or untreated mice in 
response to foreign stimulus LPS and ConA for 48 h (n = 4). The values are the mean ± SD, *P < 0.05 vs. control, **P < 0.01 vs. control
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factors such as hydrodynamic size, surface coating and 
aggregation state of the QDs will play important roles 
in determining the ultimate fate of biodistribution and 
clearance of QDs [27, 28].
From animal studies, our data manifested that lympho-
cytes from QDs-treated mice (42 days) showed inhibited 
cell viability, changed proportions of total lymphocytes, 
enhanced release of TNF-α and IL-6, and inhibited trans-
formation ability in response to LPS. It should be noted 
that in vitro exposure to QDs of lymphocytes from nor-
mal mice caused increased metabolic ability, which is 
opposite to the data obtained from lymphocytes of QDs-
treated mice. It might result from the different exposure 
time of lymphocytes to QDs. The blood clearance profile 
revealed that the CdSe/ZnS QDs can be cleared by the 
blood quickly, and then QDs migrate to immune organs. 
CdSe/ZnS QDs were found to highly accumulate in the 
spleen within 42  days of evaluation period. The long-
term exposures to QDs lead to cell viability damage to 
spleen lymphocytes.
In addition, our in  vitro data showed that CdSe/
ZnS QDs exposure led to immune dysfunction of mac-
rophages, but our in vivo data revealed no obvious overt 
toxicity towards non-specific immunity of peritoneal 
macrophages in mice. The in  vitro model reflects the 
direct bioactivity of nanoparticle-cell interaction and the 
in  vivo system provides complex information about the 
response of a physiological system to a foreign substance. 
But since the exact exposure dose of CdSe/ZnS QDs 
between the in vitro assay and in vivo experiment is hard 
to compare, and the physiological process of in vitro and 
in  vivo is not exactly the same, the results from in  vitro 
assay and in  vivo assay is not completely consistent. 
Similar with our founding, several studies have reported 
the inconsistent toxicity results from in vitro and in vivo 
assay. For example, Manna et  al. reported in vitro toxic-
ity of carbon nanotubes in human keratinocytes [29], 
whereas Schipper et  al. found no significant toxicity in 
mice [30]. Similarly, Sayes et al. illustrated a lack of cor-
relation when comparing the results between in vitro and 
in vivo toxicity assessments for fullerenes [31]. Compared 
to in vitro studies, in vivo animal model is a more prefer-
able system to be used for the toxicological evaluation of 
nanoparticles because the biological aspects of the animal 
models are more relevant to human biology in many ways.
Conclusions
Due to the ever-increasing application of QDs in many 
fields, the scale of nanotoxicology tests is expected to 
expand in the near future. The in  vitro toxicity tests in 
combination with in  vivo immunotoxicity in biological 
systems will play a pivotal role in assessing the toxicity 
of QDs and understanding the molecular mechanisms of 
nanotoxicity of QDs. Here, we report the potential toxic-
ity of CdSe/ZnS QDs on immune cells from in  vitro cell 
model and in  vivo BALB/c mice for the first time. For 
in vitro studies, our results demonstrated that CdSe/ZnS 
QDs had toxic effects on macrophages and lymphocytes. 
At high doses, CdSe/ZnS QDs caused cytotoxicity towards 
macrophages by inducing ROS generation and apopto-
sis. In addition, CdSe/ZnS QDs exposure led to suppres-
sive immune response of immune cells towards foreign 
stimuli and changed immune functionality. For in  vivo 
studies, our data demonstrated that QDs injection by tail 
vein led to the accumulation of QDs in major immune 
organs, changed proportions of lymphocytes, and sup-
pressive immune function of spleen-derived lymphocytes. 
In this regard, our results suggested that pre-exposure of 
CdSe/ZnS QDs might influence immune cell function and 
impair immune responses towards foreign stimuli, which 
in turn could result in decreased defense ability against 
infection and increased susceptibility of hosts to diseases.
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